6Kaspera R,Naraharisetti SB,Tamraz B,et al.Cerivastatin in vitro metabolism by CYP2C8 vayiants found in patients experiencing rhabdomyolysis[J].Pharmacogenet Genomics,2010,20(10):619-629.
7Pogson GW,Kindred LH,Carper BG.Rhabdmyolysis and renal failure associated with cervastatin gemfibrozil combination therapy[J].Am J Gardio,2001,83(7):1146.
9Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：346
7American Diabetes Association.Standards of medical care in dia betesd-2014[J].Diabetes Care,2014,37 (Suppl1):S14-80.
8Baek SD,Jang SJ,Park SE,et al.Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin[J].J Korean Med Sci,2011,6 (12):1634-1637.
9Filippatos TD,Elisaf MS.Fenofibrate plus simvastin (fixed-dose combination) for the treatment of dyslipidaemia[J].Exp Opin Pharmacother,2011,12 (12):1945-1958.
10Ginberg HN.The ACCORD(Action to control Cardiovascular Risk in Diabetes)Lipid trial:what we learn from subgroup analyses[J].Diabetes Care,2011,34(Suppl2):S107-108.
